CTNND1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.965600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.471200E-01
Normal-vs-Stage2
7.970600E-01
Normal-vs-Stage3
7.213000E-01
Normal-vs-Stage4
4.357200E-01
Stage1-vs-Stage2
4.829600E-01
Stage1-vs-Stage3
7.154600E-01
Stage1-vs-Stage4
1.788980E-01
Stage2-vs-Stage3
2.826800E-01
Stage2-vs-Stage4
9.636200E-02
Stage3-vs-Stage4
2.466800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.403000E-01
Normal-vs-AfricanAmerican
7.974000E-01
Normal-vs-Asian
8.566600E-01
Caucasian-vs-AfricanAmerican
6.733600E-01
Caucasian-vs-Asian
7.590600E-01
AfricanAmerican-vs-Asian
8.922200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.051400E-01
Normal-vs-Female
9.658600E-01
Male-vs-Female
2.486400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.110400E-01
Normal-vs-Age(41-60Yrs)
5.980800E-01
Normal-vs-Age(61-80Yrs)
9.229400E-01
Normal-vs-Age(81-100Yrs)
9.944600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.680200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.332400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.539200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.065700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.220000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.675000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.582800E-01
Normal-vs-Daily Drinker
8.315400E-01
Normal-vs-Weekly Drinker
8.275200E-01
Normal-vs-Occasional Drinker
5.588400E-01
Normal-vs-Social Drinker
9.711400E-01
Non Drinker-vs-Daily Drinker
3.879000E-01
Non Drinker-vs-Weekly Drinker
4.366200E-01
Non Drinker-vs-Occasional Drinker
3.786600E-01
Non Drinker-vs-Social Drinker
5.940000E-01
Daily Drinker-vs-Weekly Drinker
9.957400E-01
Daily Drinker-vs-Occasional Drinker
1.227170E-01
Daily Drinker-vs-Social Drinker
6.395800E-01
Weekly Drinker-vs-Occasional Drinker
1.521550E-01
Weekly Drinker-vs-Social Drinker
6.747200E-01
Occasional Drinker-vs-Social Drinker
1.649360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.338400E-02
Normal-vs-Grade 2
5.683700E-03
Normal-vs-Grade 3
1.044410E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.793710E-02
Grade 1-vs-Grade 3
4.597800E-04
Grade 1-vs-Grade 4
8.338400E-02
Grade 2-vs-Grade 3
4.127700E-02
Grade 2-vs-Grade 4
5.683700E-03
Grade 3-vs-Grade 4
1.044410E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.413600E-01
Normal-vs-NonDiabetic
8.837000E-01
Diabetic-vs-NonDiabetic
2.542400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.168000E-01
Normal-vs-NoPancreatitis
9.777000E-01
Pancreatitis-vs-NoPancreatitis
4.227800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.782000E-01
Normal-vs-N1
8.181000E-01
N0-vs-N1
4.925800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.865010E-01
Normal-vs-TP53-NonMutant
9.476600E-01
TP53-Mutant-vs-TP53-NonMutant
2.13559999999724E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
